These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5364147)

  • 21. Some biological characteristics of the mouse ascitic tumour NK-Ly passaged in AB-Jena-Gat.-Ko. strain mice.
    Seidlová A
    Neoplasma; 1969; 16(4):409-16. PubMed ID: 5344227
    [No Abstract]   [Full Text] [Related]  

  • 22. A possible endomitotic origin of trisomy of chromosome 13: karyological implications for murine mammary tumorigenesis.
    Dofuku R; Matsuzawa A
    Anticancer Res; 1983; 3(1):17-34. PubMed ID: 6830148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The function of the immune response in tumour growth and its genetical regulation. A new hypothesis.
    Spärck JV
    Acta Pathol Microbiol Scand; 1969; 77(1):1-23. PubMed ID: 5368236
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
    Suit H; Kastelan A
    J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
    [No Abstract]   [Full Text] [Related]  

  • 25. Properties of the rat tumour fedex-WP during long-term cultivation in vitro.
    Krenová D; Kren V; Stark O
    Neoplasma; 1968; 15(4):379-92. PubMed ID: 5684462
    [No Abstract]   [Full Text] [Related]  

  • 26. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
    Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF
    Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
    Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
    Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of immunologically competent cells in the treatment of cancer. Further experiments with a transplantable mouse tumour.
    Symes MO
    Br J Cancer; 1967 Mar; 21(1):178-83. PubMed ID: 6024508
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. I. Quantitative cell transplants into mammary-tumor-agent-positive and -free mice.
    Silobrcic V; Suit HD
    J Natl Cancer Inst; 1967 Dec; 39(6):1113-9. PubMed ID: 6079864
    [No Abstract]   [Full Text] [Related]  

  • 30. Syngeneic preference and allogeneic inhibition.
    Hellström KE; Hellström I
    Wistar Inst Symp Monogr; 1965 Aug; 3():79-93. PubMed ID: 5884667
    [No Abstract]   [Full Text] [Related]  

  • 31. Differentiation and neoplasia. Invasion and metastasis; experimental systems.
    Eccles SA
    J Pathol; 1983 Nov; 141(3):333-53. PubMed ID: 6663389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
    Frey AB
    J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavior of skin allorafts in backcross progeny of tolerant males.
    Steinmuller D
    J Natl Cancer Inst; 1967 Dec; 39(6):1247-51. PubMed ID: 4865582
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigenic characteristics of metastasizing and nonmetastasizing mammary adenocarcinomata of rat.
    Ghosh SK; Roholt OA; Kim U
    Prog Clin Biol Res; 1983; 133():227-33. PubMed ID: 6622494
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in antitumor resistance during chemical carcinogenesis].
    Savinskaia AP
    Biull Eksp Biol Med; 1984 Aug; 98(8):226-8. PubMed ID: 6432073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic differences among virus-induced mouse mammary tumors arising spontaneously in the same C3H-Crgl host.
    Vaage J; Kalinovsky T; Olson R
    Cancer Res; 1969 Jul; 29(7):1452-6. PubMed ID: 5799162
    [No Abstract]   [Full Text] [Related]  

  • 37. Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1980 Oct; 40(10):3495-3501. PubMed ID: 7438036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An alteration in tumor histocompatibility induced by neuraminidase.
    Sanford BH
    Transplantation; 1967 Sep; 5(5):1273-9. PubMed ID: 6056941
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative cytogenetic study of spontaneous mammary carcinoma and its ascitic variant in R3 mice].
    Andreescu M
    Bull Cancer; 1969; 56(2):177-86. PubMed ID: 5403365
    [No Abstract]   [Full Text] [Related]  

  • 40. Properties of the sarcomas induced by ferridextran Spofa in inbred rat strain AVN. II. The observation of H-1a and B 1 antigenity of FEDEX-AVN-3 tumour following long term in vitro cultivation.
    Krenová D; Kren V; Stark O
    Neoplasma; 1970; 17(5):505-12. PubMed ID: 5486301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.